---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-000994"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2026-01-08T23:59:59+00:00"
generated_at: "2026-05-16T11:13:37.767851+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ensysce shareholders approve share issuance to investor and incentive plan increase

## Summary
- Issuance of common stock and warrants to an investor approved: 541,882 for, 195,475 against, 1,030,540 broker non-votes.
- Amendment to 2021 Omnibus Incentive Plan approved, increasing authorized shares from 121,457 to 721,457.
- Class I directors William Chang and Lee Rauch reelected; Chang: 518,597 for, Rauch: 516,907 for.
- Ratified Baker Tilly US, LLP as independent auditor for fiscal year ending December 31, 2025.

## SEC filing metadata
- accession: 0001493152-26-000994
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2026-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315226000994/0001493152-26-000994-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315226000994/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-000994
- JSON: https://secwatch.observer/filing/0001493152-26-000994.json
- Plain text: https://secwatch.observer/filing/0001493152-26-000994.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.